GLP1R and Hypoglycemia: The efficacy of glucagon-like peptide-1 receptor agonists (GLP1-RA) in type 2 diabetes mellitus is well-established with weight loss, improved glycemic control without hypoglycemia [1], and an improvement in cardiovascular outcomes [2,3].